BRIEF-PTC Therapeutics Enters Into A Global License And Collaboration Agreement With Novartis For PTC518 Huntington's Disease Program

Reuters
02 Dec 2024
BRIEF-PTC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Enters Into A Global License And Collaboration Agreement With Novartis For PTC518 Huntington's Disease Program

Dec 2 (Reuters) - Novartis AG NOVN.S:

  • PTC THERAPEUTICS ENTERS INTO A GLOBAL LICENSE AND COLLABORATION AGREEMENT WITH NOVARTIS FOR PTC518 HUNTINGTON'S DISEASE PROGRAM

  • PTC THERAPEUTICS INC - TO RECEIVE $1 BILLION IN CASH AT CLOSING

  • PTC THERAPEUTICS INC - ELIGIBLE TO RECEIVE UP TO $1.9 BILLION IN MILESTONES

  • PTC THERAPEUTICS INC - NOVARTIS TO ASSUME GLOBAL DEVELOPMENT AND COMMERCIAL RESPONSIBILITIES

Source text: ID:nPn3HzZL0a

Further company coverage: NOVN.S

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10